- ￥1880
- 晶风生物
- TF0976R
- 中国
- 2026年03月04日
- Elisa=1:500-1000,IHC-P=1:100-500,IHC-F=1:100-500,IF=1:100-500,ICC=1:100-500,
- Rabbit
- Human,Mouse,Rat,Dog,Pig,Cow,Rabbit,Sheep,Guinea Pig,
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 抗体名：
鼻咽癌癌基因抗体
- 抗体英文名：
LPLUNC1
- 靶点：
细胞浆 细胞膜 分泌型蛋白
- 浓度：
1mg/ml
- 应用范围：
Elisa=1:500-1000,IHC-P=1:100-500,IHC-F=1:100-500,IF=1:100-500,ICC=1:100-500,
- 宿主：
Rabbit
- 适应物种：
Human,Mouse,Rat,Dog,Pig,Cow,Rabbit,Sheep,Guinea Pig,
- 保质期：
一年
- 抗原来源：
Rabbit
- 目录编号：
TF0976R
- 级别：
I级
- 库存：
10
- 供应商：
晶风生物
- 标记物：
FITC/Alexa/CY357/BIo/HRP
- 克隆性：
Polyclonal
- 保存条件：
-20
- 形态：
Liquid
- 亚型：
IgG
- 免疫原：
KLH conjugated synthetic peptide derived
- 规格：
50ul/100ul/200ul
产品名称：LPLUNC1鼻咽癌癌基因抗体
产品规格：100ul/200ul(部分有50ul，如需更大包装或其他具体规格，请咨询客服)
研究领域：肿瘤 细胞生物 免疫学等
抗体来源：Rabbit
克隆类型：Polyclonal
交叉反应：Human,Mouse,Rat,Dog,Pig,Cow,Rabbit,Sheep,
产品应用：WB=1:500-2000 ELISA=1:5000-10000 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1μg/Test IF=1:100-500 （石蜡切片需做抗原修复）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
性 状：Liquid
浓 度：1mg/ml
免 疫 原：KLH conjugated synthetic peptide derived
亚 型：IgG
纯化方法：affinity purified by Protein A
储 存 液：0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存条件：Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
LPLUNC1鼻咽癌癌基因抗体相关抗体示例（非本抗体，如需本抗体，请联系客服索要说明书）：
Sample:
Liver (Mouse) Lysate at 40 ug
Spleen (Mouse) Lysate at 40 ug
NIH/3T3 (Mouse) CellLysate at 30 ug
RAW246.7 (Mouse) CellLysate at 30 ug
Primary: Anti- IL12 at 1/300 dilution
Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution
Predicted band size: 22 kD
Observed band size: 35/36 kD
paraffin embedded (Mouse brain); Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15min; Block endogenous peroxidase by 3% hydrogen peroxide for 20 minutes; Blocking buffer (normal goat serum) at 37°C for 30min; Antibody incubation with (IL12) Polyclonal Antibody, Unconjugated at 1:400 overnight at 4°C, followed by operating according to SP Kit(Rabbit) instructions and DAB staining.
paraffin embedded (rat brain tissue); Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15min; Block endogenous peroxidase by 3% hydrogen peroxide for 20 minutes; Blocking buffer (normal goat serum) at 37°C for 30min; Antibody incubation with (IL12) Polyclonal Antibody, Unconjugated at 1:400 overnight at 4°C, followed by operating according to SP Kit(Rabbit) instructionsand DAB staining.
LPLUNC1鼻咽癌癌基因抗体
Blank control (blue line): Mouse spleen (blue).
Primary Antibody (green line): Rabbit Anti- IL12 antibody
Dilution: 1μg /10^6 cells;
Isotype Control Antibody (orange line): Rabbit IgG .
Secondary Antibody (white blue line): Goat anti-rabbit IgG-FITC
Dilution: 1μg /test.
Protocol
The cells were fixed with 70% ice-cold methanol overnight at 4℃. Cells stained with Primary Antibody for 30 min at room temperature. The cells were then incubated in 1 X PBS/2%BSA/10% goat serum to block non-specific protein-protein interactions followed by the antibody for 15 min at room temperature. The secondary antibody used for 40 min at room temperature. Acquisition of 20,000 events was performed.
Tissue/cell: rat colitis tissue; paraffin-embedded;
Antigen retrieval: citrate buffer ( 0.01M, pH 6.0 ), Boiling bathing for 15min; Block endogenous peroxidase by 3% Hydrogen peroxide for 30min; Blocking buffer (normal goat serum,at 37℃ for 20 min;
Incubation: Anti-IL-12 Polyclonal Antibody, Unconjugated 1:200, overnight at 4°C, followed by conjugation to the secondary antibody(SP-0023) and DAB staining
欢迎新老客户咨询订购：LPLUNC1鼻咽癌癌基因抗体
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验鼻咽癌是原发于鼻咽部的恶性肿瘤。在我国常见，发病率以广东省最高，有“广东癌”之称。男女病人之比例约为３：１。国内所见最小年龄为３岁，最大为８６岁，各个年龄组都可发病，而大多数在４０－６０岁之间。 鼻咽癌的特点是发病部位隐蔽，原发源很小，局部症状不明显，却已发生淋巴结转移，病人常以颈淋巴结肿大为首发症状而就医。 临床表现 1.回吸涕血是鼻咽癌常见症状，一般较晚期才出现鼻 塞。 2.耳内闭塞感、鼓膜内陷、鼓室积液、传音性耳聋，病变多为一侧性，由咽鼓管
三句话读懂一篇 CNS：高糖饮食引起线粒体损伤；长期熬夜真的
，并使其活性丧失，进一步造成纺锤体错误组装，最终阻断了细胞分裂的正常进行。基于这一机制，黑磷纳米材料被赋予了基本的抗肿瘤药物性质！这是一项跨学科交叉的研究，为生物医药领域增添新的研究视角！图 2：来源 Nature Nanotech3. Nature Medicine：攻克鼻咽癌获得重大进展每年全世界因鼻咽癌去世的人高达 14 万例。2021 年 8 月 2 日，中山大学肿瘤防治中心徐瑞华教授团队在 Nature Medicine 杂志上发表研究论文 Toripalimab or placebo
6.26 「CRISPR婴儿」计划疯狂重启 顶级科学家们表示无力阻止
adipogenic differentiationNucleic Acids Research, gkz312, https://doi.org/10.1093/nar/gkz312④ 中山大学曾益新院士等Nature Genetics最新发文：鼻咽癌EB病毒高危亚型鼻咽癌发病由遗传、环境和EB病毒因素共同导致。科学家曾提出假说，认为鼻咽癌起源于中国古代南方的百越部落。曾益新院士团队曾在2002年和2010年在Nature Genetics上发布两项研究成果，分别发现了鼻咽癌家系和散发人群的基因易感位点，从遗传
技术资料暂无技术资料 索取技术资料
